APOLLO ENDOSURGERY INVESTOR ALERT by the Former Attorney General of Louisiana
Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apollo Endosurgery, Inc. - APEN
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Apollo Endosurgery, Inc. (NasdaqGM: APEN) to Boston Scientific Corporation (NYSE: BSX). Under the terms of the proposed transaction, shareholders of Apollo will receive only $10.00 in cash for each share of Apollo that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgm-apen/ to learn more.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
Lesen Sie auch
View source version on businesswire.com: https://www.businesswire.com/news/home/20221129006135/en/
The Apollo Endosurgery Stock at the time of publication of the news with a raise of +67,83 % to 10,07EUR on Nasdaq stock exchange (29. November 2022, 22:00 Uhr).